Investigational drug · Phase 2
ES014
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Desmoid Tumor.
Phase 2Last checked: Nov 19, 2026Latest source record: Oct 21, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
4
Any phase or sponsor naming "ES014"
First trial start
2026
Apr 24, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "ES014", any sponsor or status.
Conditions studied
As listed on its trial records.
- Desmoid Tumor
Approved drugs for the same conditions: Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "ES014" as an intervention, largest first.
- A Study of ES014 in Patients With Locally Advanced or Metastatic Solid TumoursPivotal-lookingActive, not recruiting
Elpiscience (Suzhou) Biopharma, Ltd.Industry
NCT05717348 · 120 participants (planned) · Start Feb 24, 2023 · Primary completion Feb 28, 2027
Drug: ES014 · For: Solid Tumor; Locally Advanced Solid Tumor; Metastatic Solid Tumor
Sites: Shanghai, China
- A Study in Adults With Desmoid TumorsRecruiting
Elpiscience (Suzhou) Biopharma, Ltd.Industry
NCT07541430 · 50 participants (planned) · Start Apr 24, 2026 · Primary completion Jan 2028
Drug: ES014; ES014 · For: Desmoid Tumor
Sites: Beijing, China
Cancer Institute and Hospital, Chinese Academy of Medical SciencesAcademic, hospital or other
NCT06543056 · 15 participants (planned) · Start Nov 25, 2024 · Primary completion Jun 30, 2026
Drug: ES014 · For: Advanced Solid Tumor
Sites: Beijing, China
Elpiscience Biopharma, Ltd.Industry
NCT05381935 · 0 participants · Start Apr 21, 2023 · Primary completion Apr 30, 2026
Drug: ES014; ES014 · For: Advanced Solid Tumor
Newest research
PubMed records naming it or its code names, newest first.
- Decolourization of azo dye using a batch bioreactor by an indigenous bacterium Enterobacter aerogenes ES014 from the waste water dye effluent and toxicity analysis.
Al-Ansari MM, Li Z, Masood A, et al. · Environ Res 2022
Also in development for Desmoid Tumor
- varegacestatAL102Phase 31 trial
Immunome, Inc. · Desmoid, Desmoid Tumor
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.